N@N

51.34% Of All NASDAQ Trading Thursday Was Short Selling. DISK, APAB, GPRO, BPSG, APPY, INSU Highest % Of Daily Trading Volume

^{Published on 2009-10-02 07:53:11, Last Modified on 2010-12-22 14:50:34 - WOPRAI}
 

October 2, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, has reviewed the NASDAQ Daily Short Volume Report for Thursday, September 30th, 2009 and come to the following statistical conclusions. There were 6,735 stocks with daily short volume reported and total NASDAQ trading volume of 2,094,811,903 shares. Total Daily Short Volume was 1,075,574,491 shares. 51.34% of all trading on the NASDAQ Thursday was short selling. The chart below highlights 6 stocks that had unusually high percentages of their total daily trading volume attributed to short sales. Image Entertainment (NASDAQ: DISK), Appalachian Bancshares (NASDAQ: APAB), Gen-Probe (NASDAQ: GPRO), Broadpoint Gleacher Securities (NASDAQ: BPSG), AspenBio Pharma (NASDAQ: APPY) and Insituform Technologies (NASDAQ: INSU). To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net.

DATE SYMBOL SHORT VOLUME TOTAL VOLUME MARKET PERCENT

20091001 DISK 48,384 52,084 Q 92.90%

20091001 APAB 54,089 66,127 Q 81.80%

20091001 GPRO 237,581 296,493 Q 80.13%

20091001 BPSG 151,566 189,331 Q 80.05%

20091001 APPY 48,300 60,382 Q 79.99%

20091001 INSU 53,778 67,348 Q 79.85%

In late October 2008 the SEC updated Regulation SHO requiring that all short sellers must locate, borrow and deliver any shares they have shorted, no exceptions, by T+3 settlement date. If not, a buy-in must be forced by the broker dealer that the short seller transacted through by the opening of the market on T+4. Since a company first appears on the naked short list when short sellers have been failing to deliver for 5 consecutive trading days, stocks should theoretically never be on the naked short list again. BUYINS.NET will monitor the exchangesa� naked short lists daily and issue an alert and notify the SEC and FINRA should short sellers fail to deliver on any short sales.

Reg SHO Rule 204 (i) requires brokers to deliver shares on long and short sales of publicly traded equity securities by settlement date, (ii) continues to require brokers to close-out fails to deliver by the beginning of trading on T+4 for short sales and T+6 for long sales, (iii) precludes clearing brokers and their introducing brokers from selling short a security, other than on a pre-borrowed basis, if a fail to deliver in that security is not timely closed out until the fail is closed out and that close-out transaction settles, (iv) allows clearing brokers to allocate fails to introducing brokers and (v) continues to permit brokers to rely upon pre-fail credit to satisfy Rule 204's close-out requirement to avoid the pre-borrow requirements when a fail at a clearing broker has not been closed out. However, the SEC liberalized certain of these provisions in several regards. For example, permanent Rule 204 now allows a broker to close-out a fail on a long sale by borrowing the security, whereas Rule 204T had only permitted closing out long fails by buying-in, which should alleviate some of the buy-in risk for investors that experience long fails. Similar relief was extended to close-outs for market maker fails, so that a fail from a bona fide market making transaction (including short and long fails) can now be closed out by the beginning of trading on T+6 by borrowing the security. Further, Rule 204 now permits a broker to borrow securities to obtain pre-fail credit for early close-outs, whereas temporary Rule 204T only permitted pre-fail credit to be obtained by purchases of securities.

The SEC refused requests to extend the close-out deadline for fails to deliver to the close of business on the close-out deadline, choosing instead to retain the requirement that all fails be closed out by the beginning of trading on the applicable close-out deadline. The Commission also rejected requests for a fail to deliver exception that would have provided an exception from the close-out requirements if a clearing broker's fail position was below a certain amount but said that it would continue to monitor whether a de minimis or odd lot exception could be warranted.

Image Entertainment, Inc. (NASDAQ: INSU) engages in the acquisition, production, and distribution of entertainment programming in North America. It releases its library of exclusive content on various formats and platforms, including digital versatile disc, Blu-ray Disc, digital, broadcast television, cable, satellite, theatrical, and non-theatrical exploitation. The company offers an array of general and specialty content comprising feature films, comedy, music concerts, urban, theatre, documentaries, theatrical catalogue films, independent films, foreign films, youth culture/lifestyle, television, and gospel. As of March 31, 2009, it had approximately 3,200 DVD titles and 340 CD titles, as well as holds digital rights to approximately 2,000 video programs and approximately 300 audio titles containing approximately 5,100 individual tracks. The company also acquires rights to audio content for distribution via digital platforms and on CD in various genres and configurations, including albums, compilation CDs, stand-up comedy programs, broadway original cast recordings, and audio recordings from live concert event DVDs. Image Entertainment, Inc. sells its products to traditional retailers, specialty retailers, rental customers, Internet retailers, and wholesale distributors, as well as through alternative distribution, such as direct-to-consumer print catalogs, direct response campaigns, subscription service/club sales, home shopping television channels, other non-traditional sales channels, kiosks, and sub-distributors. The company was formerly known as Key International Film Distributors, Inc. and changed its name to Image Entertainment, Inc. in 1983. Image Entertainment, Inc. was founded in 1975 and is headquartered in Chatsworth, California.

Appalachian Bancshares, Inc. (NASDAQ: APAB) operates as the bank holding company for Appalachian Community Bank and Appalachian Community Bank, F.S.B. that provide various retail and commercial banking products and services to individuals and small and medium sized businesses in north Georgia; Murphy, North Carolina; and Ducktown, Tennessee. The company offers various deposit products, including checking accounts, commercial accounts, savings accounts, money market accounts, and long-term certificates of deposit. Its loan portfolio comprises commercial and residential real estate loans; construction and development loans; commercial business loans; and consumer loans for personal and household purposes, including secured and unsecured installment and term loans, home equity loans and lines of credit, and revolving lines of credit. The company also provides Internet banking and bill payment services, credit cards, safe deposit box facilities, money orders, travelersa� checks, cashiera�s checks, electronic funds transfer services, and automatic teller machine access services. As of March 31, 2009, it operated 13 full-service branches in Ellijay, East Ellijay, Blue Ridge, Blairsville, Chatsworth, Dawsonville, McCaysville, Dahlonega, and Dalton, Georgia, as well as Murphy, North Carolina; and Ducktown, Tennessee. Appalachian Bancshares, Inc. is headquartered in Ellijay, Georgia.

Gen-Probe Incorporated (NASDAQ: GPRO) develops, manufactures, and markets nucleic acid probe-based products used for the clinical diagnosis of human diseases, and for screening donated human blood in North America and internationally. The company develops nucleic acid testing that enables detection of microorganisms. It markets a portfolio of products that use technologies to detect various infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia, and fungal infections. The company also offers blood screening products for the simultaneous detection of human immunodeficiency virus (type 1), hepatitis C virus, and procleix west nile virus. In addition, it sells TIGRIS instrument that enables blood collection centers to test donorsa� blood. Further, the company develops and manufactures nucleic acid probe-based products for the detection of harmful organisms in the environment and in industrial processes. It markets and sells its clinical diagnostic products through distributors and direct sales force, as well as other products through collaborative partners. The companya�s customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. Gen-Probe Incorporated was founded in 1983 and is based in San Diego, California.

Broadpoint Gleacher Securities Group, Inc. (NASDAQ: BPSG) provides independent advice and execution in the areas of advisory services; capital raising; and research, sales, and trading to corporate and institutional clients primarily in the United States. The company also offers mergers and acquisitions advisory services, as well as restructuring and recapitalization advisory services to a range of constituents, including corporations, creditors, labor related parties, government agencies, litigation claimants, plan sponsors and stalking horse bidders, or other potential acquirers. In addition, it underwrites and places initial public offerings, follow-on public equity offerings, secondary equity offerings and direct registered placements of equity securities, and private placements of public and private equity and hybrid securities; underwrites and places public and private placements of investment grade debt, high yield debt, bank debt and convertible debt, and various other fixed income related securities; and provides liability management advisory and execution services. Further, Broadpoint Gleacher Securities Group offers proprietary debt and equity research, broad and differentiated institutional account coverage, and trading execution services for institutional investors. The company was formerly known as Broadpoint Securities Group, Inc. and changed its name to Broadpoint Gleacher Securities Group, Inc. in June 2009. Broadpoint Gleacher Securities Group, Inc. was founded in 1952 and is headquartered in New York, New York.

AspenBio Pharma, Inc. (NASDAQ: APPY), a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of drugs and diagnostics for human and animal healthcare. Its product pipeline includes AppyScore, which has completed 800 patient pivotal clinical trials for use as an aid in the diagnosis of appendicitis. The company also develops animal healthcare products focusing on reproduction, including BoviPure LH, a recombinant hormone analog that induces ovulation and reduces the risk of pregnancy loss in dairy cows; BoviPure FSH, a single-chain bovine FSH analog for super-ovulation of cows; EquiPure LH, a single-chain LH analog for horses that stimulates follicular development, as well as induces ovulation in estrous mares; and EquiPure FSH, a single-chain FSH analog for horses that assists mares through transition and for super-ovulation. In addition, it manufactures and markets approximately 20-30 purified protein products primarily for use as controls by diagnostic test kit manufacturers and research facilities to determine whether diagnostic test kits are functioning properly. The company was founded in 2000 and is based in Castle Rock, Colorado.

Insituform Technologies, Inc. (NASDAQ: INSU), together with its subsidiaries, provides proprietary trenchless technologies to rehabilitate, replace, maintain, and install underground pipes. It offers Insituform CIPP Process for the rehabilitation of sewers, pipelines, and other conduits; iPlus Infusion Process, a trenchless method used for the rehabilitation of small-diameter sewer pipelines; iPlus Composite Process for the rehabilitation of large-diameter sewer pipelines; InsituGuard, InsituFlex, and InsituFold Processes for rehabilitating transmission and distribution water mains using high-density polyethylene liners; and Thermopipe Lining System, a polyester-reinforced polyethylene lining system for the rehabilitation of distribution water mains. The company also provides iTAP Process, a robotic method for reinstating potable water service connections from inside a water main; Insituform RPP Process, a trenchless technology used for the rehabilitation of forced sewer mains and industrial pressure pipelines; Insituform PPL Process for the rehabilitation of drinking water and industrial pressure pipelines; Sliplining, a method used to push or pull a new pipeline into an old one; and Pipebursting for replacing deteriorated or undersized pipelines. In addition, Insituform Technologies offers Tite Liner process, a method of lining new and existing pipe with a corrosion and abrasion resistant high-density polyethylene pipe; and Safetyliner Liner, a grooved high-density polyethylene liner that is installed in an industrial pipeline using the Tite Liner process. It has operations in the United States, Canada, the Netherlands, France, Switzerland, Chile, Spain, Mexico, Poland, Romania, Belgium, Europe, and Asia. The company was formerly known as Insituform of North America, Inc. and changed its name to Insituform Technologies, Inc. in 1992. Insituform Technologies was founded in 1980 and is headquartered in Chesterfield, Missouri.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,650,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. Occassionally companies or third parties pay $995 per month to purchase data for information provided in monthly reports. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor. By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net